ARCHIVES

FDA Approves Votrient For Soft Tissue Sarcomas

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

WHT Participants Get “Phase Out” Help

March 11, 1988

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

Exercise May Help Combat Leukemia Patients’ Fatigue

August 28, 2009

Advocacy: Groups Urge studies Of Environmental Pollutants As Cause Of Cancer

November 5, 1999